Cited by 120Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchMedicinal Plants and Neuroprotection

Tauroursodeoxycholic acid (TUDCA) supplementation prevents cognitive impairment and amyloid deposition in APP/PS1 mice

Open access
Lo, Adrian C., Callaerts-Vegh, Zsuzsanna, Nunes, Ana F., Rodrigues, Cecília M.P., D'Hooge, Rudi·2013·Neurobiology of Disease

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease hallmarked by extracellular Aβ(1-42) containing plaques, and intracellular neurofibrillary tangles (NFT) containing hyperphosphorylated tau protein. Progressively, memory deficits and cognitive disabilities start to occur as these hallmarks affect hippocampus and frontal cortex, regions highly involved in memory. Connective tissue growth factor (CTGF) expression, which is high in the vicinity of Aβ plaques and NFTs, was found to influence γ-secretase activity, the molecular crux in Aβ(1-42) production. Tauroursodeoxycholic acid (TUDCA) is an endogenous bile acid that downregulates CTGF expression in hepatocytes and has been shown to possess therapeutic efficacy in neurodegenerative models. To investigate the possible in vivo therapeutic effects of TUDCA, we provided 0.4% TUDCA-supplemented food to APP/PS1 mice, a well-established AD mouse model. Six months of TUDCA supplementation prevented the spatial, recognition and contextual memory defects observed in APP/PS1 mice at 8 months of age. Furthermore, TUDCA-supplemented APP/PS1 mice displayed reduced hippocampal and prefrontal amyloid deposition. These effects of TUDCA supplementation suggest a novel mechanistic route for Alzheimer therapeutics.

Integrity signals

Registry

Crossref · 10.1016/j.nbd.2012.09.003

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Lo, A. C., Callaerts-Vegh, Z., Nunes, A. F., Rodrigues, C. M. P., & D'Hooge, R.
Affiliations
  • KU Leuven (BE)
  • University of Lisbon (PT)
Corresponding author
Rodrigues, Cecília M.P.
Venue
Neurobiology of Disease
Publisher
Elsevier BV
Published
2013-02
Volume
50
Pages
21-29
ISSN
0969-9961 (ISSN-L)
OpenAlex
W2023956551
Cited by
120
References
61
Citations by year
2026: 9 · 2025: 9 · 2024: 15 · 2023: 12 · 2022: 9 · 2021: 14 · 2020: 9 · 2019: 8 · 2018: 7 · 2017: 5 · 2016: 4 · 2015: 6 · 2014: 10 · 2013: 3
FWCI
4.07
Type
journal article
Language
en
Open access
Locations
  • Neurobiology of Disease (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • 7FP grant MEMOSAD
  • Federal Science Fund FWO-Vlaanderen (G.0327.08)
  • Fundacão para a Ciência e a Tecnologia (PTDC/SAU-NMC/117877/2010)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
Keywords
tauroursodeoxycholic acid, Alzheimer's disease, APP/PS1 mice, amyloid plaques, amyloid deposition, cognitive impairment, memory impairment, connective tissue growth factor, gamma-secretase, tau hyperphosphorylation, neurofibrillary tangles, hippocampus, prefrontal cortex, dietary supplementation, bile acids
MeSH terms
Alzheimer Disease, Animals, Behavior, Animal, Cholagogues and Choleretics, Cognition Disorders, Disease Models, Animal, Male, Mice, Transgenic, Taurochenodeoxycholic Acid, Amyloid beta-Protein Precursor, Dietary Supplements, Mice, Presenilin-1, Amyloidogenic Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review